Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus

被引:70
作者
Duarte-Delgado, Nancy P. [2 ]
Vasquez, Gloria [1 ,3 ]
Ortiz-Reyes, Blanca L. [1 ]
机构
[1] Univ Antioquia, Fac Med, Grp Inmunol Celular & Inmunogenet GICIG, Medellin, Colombia
[2] Univ Manuela Beltran, Dept Ciencias Basicas, Bogota, Colombia
[3] Univ Antioquia, Fac Med, GRUA, Medellin, Colombia
关键词
Neuropsychiatric systemic lupus erythematosus; Autoantibodies; Cytokines; Complement; Blood-brain barrier and mechanisms; GLUTAMATE-RECEPTOR; CEREBROSPINAL-FLUID; AUTOANTIBODIES; ANTIBODIES; INTEGRITY; CYTOKINES; MODEL; PATHOGENESIS; ASSOCIATION; INVOLVEMENT;
D O I
10.1016/j.autrev.2018.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease that can involve nervous system commitment known as neuropsychiatric systemic lupus erythematosus (NPSLE). The diagnostic of NPSLE is complex because the symptoms range from focal symptoms (e.g., strokes, thrombotic events) to diffuse disorders affecting cognition, mood and level of consciousness (e.g. acute confusional state, psychosis). Both type of manifestations of NPSLE differ in their pathological mechanisms. The focus of this review will be on the mechanisms that lead to the blood-brain barrier (BBB) disruption and to the neuroinflammation related with the diffuse manifestations of NPSLE.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 72 条
[1]  
Aranow C, 2013, PATHOGENESIS NERVOUS, V6, DOI [10.1016/B978-1-4377-1893-5.00028-5, DOI 10.1016/B978-1-4377-1893-5.00028-5]
[2]   Glutamate Receptor Biology and its Clinical Significance in Neuropsychiatric Systemic Lupus Erythematosus [J].
Aranow, Cynthia ;
Diamond, Betty ;
Mackay, Meggan .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (01) :187-+
[3]   Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus [J].
Arinuma, Yoshiyuki ;
Yanagida, Tamiko ;
Hirohata, Shunsei .
ARTHRITIS AND RHEUMATISM, 2008, 58 (04) :1130-1135
[4]  
Banks WA, 2008, NEUROIMMUNE, V6, P93
[5]  
BLATTEIS CM, 1992, PROG BRAIN RES, V91, P409
[6]  
BLATTEIS CM, 1990, YALE J BIOL MED, V63, P133
[7]   ASSOCIATION BETWEEN LUPUS PSYCHOSIS AND ANTI-RIBOSOMAL P PROTEIN ANTIBODIES [J].
BONFA, E ;
GOLOMBEK, SJ ;
KAUFMAN, LD ;
SKELLY, S ;
WEISSBACH, H ;
BROT, N ;
ELKON, KB .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :265-271
[8]   CLINICAL AND SEROLOGIC ASSOCIATIONS OF THE ANTIRIBOSOMAL P PROTEIN ANTIBODY [J].
BONFA, E ;
ELKON, KB .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :981-985
[9]  
Brown KA, 2001, INT IMMUNOPHARMACOL, V1, P2043
[10]   Pathogenesis of human systemic lupus erythematosus: recent advances [J].
Crispin, Jose C. ;
Liossis, Stamatis-Nick C. ;
Kis-Toth, Katalin ;
Lieberman, Linda A. ;
Kyttaris, Vasileios C. ;
Juang, Yuang-Taung ;
Tsokos, George C. .
TRENDS IN MOLECULAR MEDICINE, 2010, 16 (02) :47-57